Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-010614
Filing Date
2017-09-14
Accepted
2017-09-14 16:34:13
Documents
58
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 524706
2 ex31-1.htm EX-31.1 10924
3 ex31-2.htm EX-31.2 12281
4 ex32-1.htm EX-32.1 8366
5 ex32-2.htm EX-32.2 7490
  Complete submission text file 0001493152-17-010614.txt   3708228

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE obmp-20170630.xml EX-101.INS 492684
7 XBRL SCHEMA FILE obmp-20170630.xsd EX-101.SCH 41348
8 XBRL CALCULATION FILE obmp-20170630_cal.xml EX-101.CAL 57860
9 XBRL DEFINITION FILE obmp-20170630_def.xml EX-101.DEF 212656
10 XBRL LABEL FILE obmp-20170630_lab.xml EX-101.LAB 343811
11 XBRL PRESENTATION FILE obmp-20170630_pre.xml EX-101.PRE 288492
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

EIN.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 171085978
SIC: 2834 Pharmaceutical Preparations